GO:0033600 negative regulation of mammary gland epithelial cell proliferation: Regulatory Mechanisms, Genes, Functions and Research Methods
Research-grade guide for scientists and biopharma professionals
Key Takeaways
• GO:0033600 describes any process that stops, prevents or reduces the rate or extent of mammary gland epithelial cell proliferation [1, 6].
• This negative regulation is essential for normal mammary gland development, functional differentiation, and tissue homeostasis [3, 5].
• Key negative regulators include TGF-beta, Id-1, TDP-43, and GPR30, which modulate cell cycle progression and signaling pathways [1, 5, 7, 8].
• Dysregulation of this process contributes to breast cancer, adenosquamous mammary carcinoma, and other proliferative disorders.
• CRISPR knockout, point mutation, knock-in, and overexpression models enable precise interrogation of these regulatory mechanisms [4, 7, 8].
• Studying GO:0033600 provides insights into developmental biology, lactation, and potential therapeutic targets for breast cancer [2, 5].
Description
The Gene Ontology term GO:0033600, negative regulation of mammary gland epithelial cell proliferation, defines any biological process that stops, prevents, or reduces the rate or extent of proliferation of mammary gland epithelial cells [1, 6]. This process is fundamental to normal mammary gland biology, ensuring proper ductal morphogenesis, alveolar differentiation, and the cessation of growth after lactation [3, 5]. In ruminants, for example, the regulation of cell number in the mammary gland involves controlled exfoliation and reduced proliferation during involution. Understanding this negative regulation is critical because its disruption can lead to uncontrolled epithelial expansion, a hallmark of breast cancer and other mammary pathologies. Researchers study GO:0033600 to uncover molecular brakes on proliferation, identify tumor suppressors, and develop targeted interventions for breast disease [5, 7]. The term encompasses diverse signaling pathways, including TGF-beta, growth factor withdrawal, and cell cycle inhibitors, which collectively maintain tissue homeostasis [5, 6]. This article synthesizes authoritative QuickGO data and verified PubMed literature to provide a comprehensive overview of the mechanisms, genes, and research methods associated with GO:0033600.
negative regulation of mammary gland epithelial cell proliferation At A Glance
| GO ID | GO:0033600 |
|---|---|
| GO term | negative regulation of mammary gland epithelial cell proliferation |
| Ontology | biological_process |
| Synonym | down regulation of mammary gland epithelial cell proliferation; down-regulation of mammary gland epithelial cell proliferation; downregulation of mammary gland epithelial cell proliferation; inhibition of mammary gland epithelial cell proliferation |
| Major function | Stops, prevents or reduces the rate or extent of mammary gland epithelial cell proliferation |
| Related processes | Cell cycle arrest, differentiation, apoptosis, TGF-beta signaling |
| Key regulators | TGF-beta, Id-1, TDP-43, GPR30, TSG101 |
| Disease relevance | Breast cancer, adenosquamous mammary carcinoma, developmental abnormalities |
What Is GO:0033600?
GO:0033600 is a biological process term that refers to any mechanism that negatively regulates, or reduces, the proliferation of epithelial cells in the mammary gland. It includes processes that inhibit cell cycle progression, promote differentiation, or trigger cell death specifically in mammary epithelial cells, thereby controlling tissue size and function [1, 6].
Why Is negative regulation of mammary gland epithelial cell proliferation Important in Cell Biology?
GO:0033600 is crucial for understanding how the mammary gland maintains tissue homeostasis and prevents tumorigenesis. Negative regulation of epithelial proliferation ensures proper developmental timing, limits expansion during pregnancy and lactation, and promotes involution after weaning [2, 3]. Loss of this regulation can result in hyperplasia and cancer, making it a focal point for breast cancer research [4, 5]. Moreover, this process is conserved across species, from rodents to ruminants, and its study informs agricultural milk production and human health [2, 3].
• Maintains normal mammary gland architecture and function by preventing excessive epithelial growth.
• Essential for developmental transitions, including puberty, pregnancy, lactation, and involution [2, 5].
• Acts as a barrier against breast cancer initiation and progression.
• Involves tumor suppressors and signaling pathways that are frequently mutated in cancer [5, 7].
• Provides targets for therapeutic intervention in breast cancer and other proliferative disorders.
• Influences milk production efficiency in dairy animals through regulation of cell number [2, 3].
• Helps researchers understand stem cell quiescence and differentiation in the mammary gland.
• Serves as a model for studying negative regulation of proliferation in other epithelial tissues.
What Happens During negative regulation of mammary gland epithelial cell proliferation?
Initiation by Growth Inhibitory Signals
In simple terms: The process starts when signals that tell cells to stop dividing are received.
Negative regulation of mammary epithelial cell proliferation is often initiated by extracellular cues such as TGF-beta, which binds to its receptors and activates intracellular signaling cascades. Other inhibitory signals include growth factor withdrawal, contact inhibition, and differentiation factors that shift cells from a proliferative to a quiescent state. These signals converge on cell cycle machinery to halt progression.
Cell Cycle Arrest
In simple terms: The cell cycle is paused, preventing cells from dividing.
Upon receiving inhibitory signals, mammary epithelial cells undergo cell cycle arrest, typically at the G1/S checkpoint. This involves upregulation of cyclin-dependent kinase inhibitors such as p21 and p27, and downregulation of cyclins and CDKs. TGF-beta, for example, suppresses c-Myc and induces p15, leading to retinoblastoma protein hypophosphorylation and G1 arrest. This arrest is a hallmark of negative regulation.
Promotion of Differentiation
In simple terms: Cells mature into specialized milk-producing cells instead of dividing.
Negative regulation of proliferation is tightly linked to functional differentiation of mammary epithelial cells. TGF-beta not only inhibits growth but also promotes differentiation and milk protein expression. Id-1, a helix-loop-helix protein, regulates mammary epithelial cell phenotypes by inhibiting differentiation and promoting proliferation; its downregulation is associated with negative regulation. Thus, differentiation and growth arrest are coordinated to ensure proper gland function.
Apoptosis and Exfoliation
In simple terms: Some cells are programmed to die or be shed to reduce cell numbers.
In addition to cell cycle arrest, negative regulation can involve apoptosis or exfoliation of epithelial cells. In ruminants, the exfoliation process in milk contributes to the regulation of cell number in the mammary gland. During involution, extensive apoptosis reduces epithelial cell mass, a process regulated by TGF-beta and other factors. This ensures timely regression of the gland after lactation.
Maintenance of Quiescence
In simple terms: Cells remain in a resting state until needed.
In the mature gland, negative regulation maintains epithelial cells in a quiescent state. TDP-43 is required for mammary gland repopulation and proliferation, but its absence leads to reduced proliferation, indicating a role in balancing quiescence and activation. GPR30 mediates cell proliferation via MEK/ERK and PI3K/AKT pathways, and its negative regulation may involve suppression of these pathways. This quiescence is reversible during pregnancy to allow alveolar expansion.
Key Genes Involved in GO:0033600 negative regulation of mammary gland epithelial cell proliferation
The following genes and proteins are key players in the negative regulation of mammary gland epithelial cell proliferation, as supported by published literature.
| Gene | Major Role | Research Relevance |
|---|---|---|
| TGFB1 | Inhibits proliferation and promotes differentiation via SMAD signaling | Central negative regulator; knockout models show hyperplasia |
| ID1 | Helix-loop-helix protein that inhibits differentiation and promotes proliferation | Its downregulation is associated with negative regulation |
| TDP43 | RNA-binding protein required for mammary gland repopulation and proliferation | Knockout reduces proliferation; links RNA processing to growth control |
| GPR30 | G protein-coupled receptor mediating proliferation via MEK/ERK and PI3K/AKT | Its inhibition may contribute to negative regulation |
| TSG101 | Tumor susceptibility gene; overexpression causes adenosquamous carcinoma | Dysregulation disrupts negative regulation |
| CDKN1A | Cyclin-dependent kinase inhibitor p21; induces cell cycle arrest | Mediates TGF-beta-induced growth arrest |
| CDKN1B | Cyclin-dependent kinase inhibitor p27; blocks G1/S transition | Key effector of negative regulation |
| MYC | Proto-oncogene promoting proliferation; downregulated by TGF-beta | Its suppression is required for negative regulation |
| CCND1 | Cyclin D1; drives G1 progression; inhibited by TGF-beta | Target of negative regulation |
| SMAD3 | TGF-beta signaling mediator; activates growth inhibitory genes | Essential for TGF-beta-mediated arrest |
| SMAD4 | Common SMAD; transduces TGF-beta signals | Loss impairs negative regulation |
| ESR1 | Estrogen receptor alpha; promotes proliferation; its downregulation reduces growth | Hormonal control of proliferation |
| EGFR | Epidermal growth factor receptor; stimulates proliferation; inhibited by negative regulators | Growth factor signaling node |
| IGF1R | Insulin-like growth factor 1 receptor; promotes proliferation | Target of negative regulation |
| STAT5 | Transcription factor for milk protein genes; also supports differentiation | Links differentiation to growth arrest |
| GATA3 | Transcription factor essential for mammary epithelial differentiation | Promotes differentiation and limits proliferation |
| NFKB1 | Transcription factor with context-dependent roles in proliferation | May mediate inhibitory signals |
| PTEN | Lipid phosphatase that inhibits PI3K/AKT; tumor suppressor | Loss leads to unchecked proliferation |
How Is negative regulation of mammary gland epithelial cell proliferation Regulated?
The negative regulation of mammary gland epithelial cell proliferation is controlled by a complex network of signaling pathways. TGF-beta is a master regulator, activating SMAD-dependent and independent pathways to inhibit proliferation and promote differentiation. Growth factor signaling through EGFR, IGF1R, and GPR30 can be suppressed to reduce proliferation [6, 7]. Cell cycle inhibitors such as p21 and p27 are upregulated, while cyclins and CDKs are downregulated. Hormonal cues, including estrogen and progesterone, modulate proliferation during the estrous cycle and pregnancy. Additionally, RNA-binding proteins like TDP-43 influence proliferation by regulating mRNA stability and translation. The balance between positive and negative regulators determines the proliferative state of mammary epithelial cells.
negative regulation of mammary gland epithelial cell proliferation and Human Disease
| Gene | Disease / Biology | Potential Experimental Model |
|---|---|---|
| TSG101 | Adenosquamous mammary carcinoma | Overexpression in mouse mammary gland |
| TGFB1 | Breast cancer, developmental defects | Knockout or conditional knockout in mice |
| PTEN | Breast cancer, Cowden syndrome | Knockout in mammary epithelial cells |
| ID1 | Breast cancer, impaired differentiation | Overexpression or knockout in cell lines |
| TDP43 | Mammary gland repopulation defect | Knockout in mouse mammary stem cells |
Breast Cancer
Loss of negative regulation of mammary epithelial cell proliferation is a hallmark of breast cancer. Overexpression of TSG101 causes adenosquamous mammary carcinoma in mice, demonstrating that disrupting growth control leads to tumorigenesis. Mutations in TGF-beta signaling components, such as SMAD4, are found in human breast cancers and impair growth inhibition. PTEN loss, which activates PI3K/AKT, also bypasses negative regulation and promotes proliferation. Thus, restoring negative regulation is a therapeutic goal.
Developmental Abnormalities
Impaired negative regulation can cause developmental defects in the mammary gland. For instance, Id-1 overexpression, which inhibits differentiation and promotes proliferation, disrupts normal ductal morphogenesis. TDP-43 knockout mice show defective mammary gland repopulation, indicating that proper regulation of proliferation is essential for gland development. These findings highlight the importance of negative regulation in tissue architecture.
Lactation and Involution Disorders
In ruminants, the exfoliation process in milk regulates cell number, and its dysregulation can affect milk production. During involution, failure to negatively regulate proliferation and apoptosis can lead to mastitis or insufficient regression [2, 5]. Understanding these processes can improve dairy animal health and productivity.
From negative regulation of mammary gland epithelial cell proliferation-Related Genes to Experimental Models
| Research Question | Suitable Model |
|---|---|
| Does gene X negatively regulate mammary epithelial proliferation? | CRISPR knockout in mammary epithelial cell lines (e.g., MCF10A) |
| Does a point mutation in gene Y affect its growth-inhibitory function? | CRISPR point mutation knock-in in primary mammary epithelial cells |
| Does overexpression of gene Z suppress proliferation? | CRISPR knock-in of a constitutive promoter or lentiviral overexpression |
| How does a tagged version of protein W localize during growth arrest? | CRISPR knock-in of fluorescent or epitope tag |
| What is the role of gene V in mammary gland development? | Conditional knockout in mouse mammary gland |
| Can a candidate gene be validated as a tumor suppressor? | CRISPR library screening in organoids |
How to Study the negative regulation of mammary gland epithelial cell proliferation Process
| Method | What It Measures | Typical Application |
|---|---|---|
| RNA-seq | Global gene expression changes | Identify pathways altered during growth arrest |
| EdU incorporation | DNA synthesis and proliferation rate | Validate negative regulation by candidate genes |
| Western blot | Protein expression and phosphorylation | Assess cell cycle regulators and signaling |
| Co-IP | Protein-protein interactions | Map signaling complexes |
| CRISPR knockout | Loss-of-function effects | Determine if gene is required for negative regulation |
| CRISPR knock-in | Tagged or mutant protein expression | Study localization and function |
| Mammary gland whole mount | Ductal morphology and proliferation | In vivo developmental studies |
| Flow cytometry | Cell cycle distribution | Quantify G1 arrest |
Transcriptomic Analysis
RNA sequencing (RNA-seq) is widely used to identify genes and pathways differentially expressed during negative regulation of mammary epithelial cell proliferation. For example, TGF-beta treatment of mammary epithelial cells followed by RNA-seq reveals upregulation of cell cycle inhibitors and downregulation of proliferation genes. This method provides a global view of transcriptional changes.
Proliferation Assays
Functional assays such as EdU incorporation, MTT, and colony formation measure the rate of cell proliferation. These are essential to confirm that a candidate gene negatively regulates proliferation. For instance, knockdown of TDP-43 reduces proliferation in mammary epithelial cells, as shown by EdU staining. Such assays are standard in validating GO:0033600.
Protein-Protein Interaction Studies
Co-immunoprecipitation (co-IP) and mass spectrometry can identify interaction partners of key regulators. For example, SMAD3 interactions with transcription factors during TGF-beta signaling have been mapped. These methods elucidate the molecular mechanisms of negative regulation.
In Vivo Models
Mouse genetics, including knockout and transgenic models, are crucial for studying negative regulation in a physiological context. Mammary gland transplantation assays and whole-mount staining assess ductal development and proliferation. Ruminant models provide insights into lactation-related regulation.
How CRISPR Can Be Used to Study GO:0033600 negative regulation of mammary gland epithelial cell proliferation
Knockout
CRISPR knockout is used to delete candidate genes and assess whether their loss increases mammary epithelial cell proliferation, thereby confirming their role in negative regulation. For example, knocking out TDP-43 in mammary epithelial cells reduces proliferation, indicating it is a positive regulator, while knocking out PTEN increases proliferation, confirming its negative regulatory role [6, 8]. Knockout models are essential for causal inference.
Point Mutation
Point mutations can be introduced to mimic cancer-associated missense mutations or to abrogate specific phosphorylation sites. For instance, mutating SMAD3 phosphorylation sites can disrupt TGF-beta-mediated growth inhibition. Such models help dissect signaling mechanisms without confounding effects of complete gene loss.
Knock-in
Knock-in of reporter genes or epitope tags allows visualization and tracking of proteins involved in negative regulation. For example, knocking in a fluorescent tag on TDP-43 enables live-cell imaging of its localization during growth arrest. Knock-in of inducible promoters can also control gene expression temporally.
Overexpression
CRISPR activation (CRISPRa) or lentiviral overexpression is used to ectopically express candidate negative regulators. Overexpression of TSG101 in mouse mammary glands causes adenosquamous carcinoma, demonstrating that dysregulated overexpression can disrupt normal regulation. Overexpression models are valuable for gain-of-function studies.
How EDITGENE Supports negative regulation of mammary gland epithelial cell proliferation Research
Researchers studying negative regulation of mammary gland epithelial cell proliferation-related genes often need to determine whether a candidate gene is causally involved in growth inhibition. EDITGENE provides a comprehensive suite of CRISPR-based services to accelerate this research, from gene knockout to precise point mutations and library screening.
Contact EDITGENE today to design your custom CRISPR model for negative regulation of mammary gland epithelial cell proliferation research.
Frequently Asked Questions About negative regulation of mammary gland epithelial cell proliferation
What is GO:0033600?
GO:0033600 is the Gene Ontology term for negative regulation of mammary gland epithelial cell proliferation, describing any process that stops or reduces the proliferation of mammary epithelial cells [1, 6].
What genes are involved in negative regulation of mammary gland epithelial cell proliferation?
Key genes include TGFB1, ID1, TDP43, GPR30, TSG101, CDKN1A, CDKN1B, and PTEN, among others [1, 4, 5, 7, 8].
How does TGF-beta inhibit mammary epithelial cell proliferation?
TGF-beta activates SMAD signaling, upregulates CDK inhibitors like p15 and p21, downregulates c-Myc, and causes G1 cell cycle arrest [5, 6].
What is the role of TDP-43 in mammary gland proliferation?
TDP-43 is required for mammary gland repopulation and proliferation; its knockout reduces epithelial proliferation, indicating a positive role, but it may also influence negative regulation through RNA processing.
Can CRISPR be used to study negative regulation of mammary epithelial proliferation?
Yes, CRISPR knockout, point mutation, knock-in, and overexpression models are widely used to dissect gene function in this process [4, 7, 8].
What diseases are associated with dysregulation of GO:0033600?
Breast cancer, adenosquamous mammary carcinoma, and developmental abnormalities are linked to loss of negative regulation [4, 5].
How is GPR30 involved in mammary epithelial cell proliferation?
GPR30 mediates proliferation via MEK/ERK and PI3K/AKT pathways; its inhibition may contribute to negative regulation.
What methods are used to measure mammary epithelial cell proliferation?
EdU incorporation, MTT assay, colony formation, and flow cytometry are common methods to quantify proliferation [6, 8].
What is the role of Id-1 in mammary epithelial cells?
Id-1 is a helix-loop-helix protein that inhibits differentiation and promotes proliferation; its downregulation is associated with negative regulation.
How does TSG101 overexpression affect the mammary gland?
Overexpression of TSG101 causes adenosquamous mammary carcinoma in mice, indicating that disrupting negative regulation leads to tumorigenesis.
Conclusion
GO:0033600, negative regulation of mammary gland epithelial cell proliferation, is a critical biological process that maintains tissue homeostasis and prevents breast cancer. Through the action of TGF-beta, cell cycle inhibitors, and other regulators, it ensures proper mammary gland development and function. Dysregulation of this process contributes to tumorigenesis and developmental defects. CRISPR-based models and advanced omics technologies are powerful tools to dissect the underlying mechanisms. EDITGENE offers comprehensive services to support researchers in this field, from knockout to library screening, accelerating discoveries that could lead to new therapies.
References
- 1. Lin CQ et al.. 1999. Regulation of mammary epithelial cell phenotypes by the helix-loop-helix protein, Id-1.. Endocr Relat Cancer 6(1):49-50 PMID: 10732787
- 2. Herve L et al.. 2016. Regulation of cell number in the mammary gland by controlling the exfoliation process in milk in ruminants.. J Dairy Sci 99(1):854-63 PMID: 26433413
- 3. Meyer MJ et al.. 2006. Developmental and nutritional regulation of the prepubertal bovine mammary gland: II. Epithelial cell proliferation, parenchymal accretion rate, and allometric growth.. J Dairy Sci 89(11):4298-304 PMID: 17033017
- 4. Dennaoui R et al.. 2025. Overexpression of TSG101 causes the development of adenosquamous mammary carcinoma.. Breast Cancer Res 27(1):126 PMID: 40624726
- 5. Smith GH. 1996. TGF-beta and functional differentiation.. J Mammary Gland Biol Neoplasia 1(4):343-52 PMID: 10887508
- 6. Stull MA et al.. 2004. Growth factor regulation of cell cycle progression in mammary epithelial cells.. J Mammary Gland Biol Neoplasia 9(1):15-26 PMID: 15082915
- 7. Zhao Y et al.. 2022. G protein-coupled receptor 30 mediates cell proliferation of goat mammary epithelial cells via MEK/ERK&PI3K/AKT signaling pathway.. Cell Cycle 21(19):2027-2037 PMID: 35659445
- 8. Zhao L et al.. 2019. TDP-43 is Required for Mammary Gland Repopulation and Proliferation of Mammary Epithelial Cells.. Stem Cells Dev 28(14):944-953 PMID: 31062657
